The Enterprise Value as of December 2025 (TTM) for Orient EuroPharma Co., Ltd. (4120.TWO) is 5.57B

According to Orient EuroPharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.57B. This represents a change of -21.53% compared to the average of 7.10B of the last 4 quarters.

Orient EuroPharma Co., Ltd. (4120.TWO) Historical Enterprise Value (quarterly & annually)

How has 4120.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Orient EuroPharma Co., Ltd. over the last ten years is 5.76B. The current 5.57B Enterprise Value has changed 9.58% with respect to the historical average. Over the past ten years (40 quarters), 4120.TWO's Enterprise Value was at its highest in in the June 2024 quarter at 8.02B. The Enterprise Value was at its lowest in in the December 2022 quarter at 5.87B.

Orient EuroPharma Co., Ltd. (4120.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Orient EuroPharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Orient EuroPharma Co., Ltd. (4120.TWO) Average Enterprise Value

How has 4120.TWO Enterprise Value performed in the past?

The current Enterprise Value of Orient EuroPharma Co., Ltd. (4120.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Orient EuroPharma Co., Ltd. (4120.TWO) Enterprise Value vs. Peers

How is 4120.TWO’s Enterprise Value compared to its peers?

Orient EuroPharma Co., Ltd.’s Enterprise Value is greater than Senhwa Biosciences, Inc. (2.72B), greater than Energenesis Biomedical CO.,LTD. (3.40B), greater than Formosa Pharmaceuticals, Inc. (4.03B), greater than BRIM Biotechnology, Inc. (2.96B), greater than AnnJi (3.95B), greater than Medigen Biotechnology Corp. (4.38B), greater than Nang Kuang Pharmaceutical Co., Ltd. (4.16B), less than Bionime Corporation (6.64B), greater than TWi Biotechnology, Inc. (1.72B), greater than Maxigen Biotech Inc. (3.24B),

Build a custom stock screener for Orient EuroPharma Co., Ltd. (4120.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orient EuroPharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orient EuroPharma Co., Ltd. (4120.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orient EuroPharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.